Upregulation of PGC-1α-mediated mitochondrial biogenesis observed in the P2Y2R knockout mouse model ameliorates damage and steatosis associated with NAFLD [635]. Here, PPARGC1A is linked to metabolic dysfunction-associated steatotic liver disease.